Following yesterday’s review of a dozen key oral abstract sessions to watch out for at ASCO18 next month including lung cancer and others, we now take a look at the other side of the coin with a dozen key poster abstracts to explore.
- Which topics jump out this year?
- What new targets and molecules are the emergent gems to think about?
- What can we learn from translational and early combination clinical data?
Take a walk with us on our journey to Chicago ahead of the data drop at 5pm…